Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
While results vary from person to person, early intervention is valuable as nerve damage may worsen over time without appropriate support
#PharmaStrategy #MedicoMarketing #MedicalAffairs #PharmaLeadership #GLP1 #DiabetesCare #ObesityManagement #HealthcareInnovation #PharmaIndia #EmergingMarkets #MarketAccess #PharmaCommercial #HealthcareLeadership #IndianPharmaLeaders To view or add a comment, sign in An exciting milestone in the GLP-1 landscape in India
This research and subsequent call-to-action was part of a multi-disciplinary team effort across University of California, Irvine, and included the UCI School of Medicine, UCI School of Pharmacy and Pharmaceutical Science and the UCI Institute for Clinical and Translational Science.
Government policies like Medicare price negotiation may lower costs for certain beneficiaries once they take effect, and broader policy pressure may encourage manufacturers to expand discount programs, patient assistance options, or cash-pay pricing strategies but these changes tend to roll out gradually and may not benefit all patients equally
US$ 23.73
US$ 28.57
US$ 26.52
